Table I.
Clinical association of miR-383-5p expression in lung adenocarcinoma.
| Relative miR-383-5p expression level | ||||
|---|---|---|---|---|
| Group | No. of patients | Low | High | P-value |
| Paraneoplastic tissues | 72 | 23 | 49 | 0.0025 |
| Carcinoma tissue | 72 | 42 | 30 | |
| Sex | 0.6356 | |||
| Male | 40 | 22 | 18 | |
| Female | 32 | 15 | 17 | |
| Age, years | 1.0000 | |||
| >65 | 39 | 18 | 21 | |
| ≤65 | 33 | 15 | 18 | |
| Size of carcinoma, cm | 0.0309 | |||
| >3 | 29 | 18 | 11 | |
| ≤3 | 43 | 15 | 28 | |
| TNM stage | 0.2381 | |||
| I–II | 35 | 15 | 20 | |
| III–IV | 37 | 22 | 15 | |
| Degree of differentiation | 0.0299 | |||
| Well and moderately | 43 | 16 | 27 | |
| Poorly | 29 | 19 | 10 | |
| Lymph node metastasis | 1.000 | |||
| Negative | 31 | 17 | 14 | |
| Positive | 41 | 23 | 18 | |
| Distant metastasis | 0.6376 | |||
| Negative | 37 | 17 | 20 | |
| Positive | 35 | 19 | 16 | |
Differences between variables were assessed by the Fisher's exact test. miR, microRNA; TNM, tumor-node-metastasis.